This study targets patients with swallowing disorders after ischemic stroke as the research population. Patients need to meet the following diagnostic criteria for ischemic stroke: The diagnostic criteria refer to the "Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2023" compiled by the Neurology Branch of the Chinese Medical Association and the Cerebrovascular Disease
Conditions
Interventions
acupuncture+placebo group:acupuncture+placebo
electroacupuncture+placebo group:electroacupuncture+placebo
electroacupuncture+NGF group:electroacupuncture+NGF
acupuncture+NGF group:acupuncture+NGF
Sponsors
The Third Affiliated Hospital of Zhejiang Chinese Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. First ischemic stroke patients confirmed by brain CT/MRI; 2. Ischemic stroke occurs 2-6 months after onset; 3. Age: 18 years old = 80 years old; 4. Confirmed swallowing disorders through swallowing imaging; 5. Can accept acupuncture, electroacupuncture treatment, and buttock muscle injection with good compliance; 6. The patient or legal representative provides informed consent and signs the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Individuals with swallowing disorders prior to the onset of the disease, or those with swallowing disorders caused by non ischemic stroke, such as head and neck tumors, esophageal tumors, myasthenia gravis, Guillain Barr é syndrome, etc; 2. Patients with severe heart, liver, kidney dysfunction and severe coagulation dysfunction; 3. Other abnormal examinations have been determined by the researcher to be unsuitable for participation in this study; 4. Multiple relapses of stroke, previous cranial surgery, or cerebral infarction caused by trauma, brain tumors, etc; 5. Individuals with severe neurological deficits prior to ischemic stroke, such as visual and auditory impairments, aphasia, and dementia, Severe hemiplegia, etc; 6. Pregnant, planned pregnant or lactating women; 7. Individuals with a history of fainting from needles and those with infected skin at the acupuncture site; 8. Carriers of implantable cardiac defibrillators, conductive metal foreign bodies in the body, or pacemakers; 9. NGF allergy patients; 10. Those who are currently participating in other clinical trials or have completed other clinical trials within 3 months;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FOIS; | — |
Secondary
| Measure | Time frame |
|---|---|
| DOSS;fNIRS;VFSS;PAS; | — |
Countries
China
Contacts
Public ContactJiangsong Zhang
The Third Affiliated Hospital of Zhejiang Chinese Medical University
Outcome results
None listed